MoonLake Immunotherapeutics
MLTX53.320USD
+0.400+0.76%
收盤 08/04, 16:00（美東）報價延遲15分鐘
3.38B總市值
虧損本益比TTM
關於 MoonLake Immunotherapeutics 公司
MoonLake Immunotherapeutics 前身爲 Helix Acquisition Corp，是一家從事醫療保健行業的瑞士公司。該公司是一家臨牀階段的生物製藥公司，專注於開發治療免疫疾病的藥物，包括炎症性皮膚病和關節病。該公司開發了三特異性納米抗體 Sonelokimab (SLK)，其目的是靶向和穿透難以到達的發炎組織。SLK 是一種在深層皮膚和關節中富集度增強且靶標結合力強的分子。SLK 通過獨立抑制引起患者炎症的天然 IL-17 A/A、A/F 和 F/F 二聚體來抑制 IL-17A 和 IL-17F 抑制以治療炎症性疾病。
公司簡介
公司代碼MLTX
公司名稱MoonLake Immunotherapeutics
上市日期Oct 20, 2020
CEODr. Jorge Santos Da Silva
員工數量100
證券類型Ordinary Share
年結日Oct 20
公司地址Dorfstrasse 29
城市ZUG
上市交易所NASDAQ Capital Market Consolidated
國家Switzerland
郵編6300
電話41415108022
網址https://moonlaketx.com/
公司代碼MLTX
上市日期Oct 20, 2020
CEODr. Jorge Santos Da Silva
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Kristian Reich
Dr. Kristian Reich
Chief Scientific Officer
Chief Scientific Officer
3.08M
--
Dr. Jorge Santos Da Silva
Dr. Jorge Santos Da Silva
Chief Executive Officer, Director
Chief Executive Officer, Director
3.08M
--
Mr. Matthias Bodenstedt
Mr. Matthias Bodenstedt
Chief Financial Officer
Chief Financial Officer
616.67K
--
Mr. Simon Sturge
Mr. Simon Sturge
Independent Chairman of the Board
Independent Chairman of the Board
171.98K
--
Dr. Andrew J. Phillips
Dr. Andrew J. Phillips
Independent Director
Independent Director
--
--
Dr. Atif Khan
Dr. Atif Khan
Director - Strategic Planning and Projects
Director - Strategic Planning and Projects
--
--
Ms. Catherine Moukheibir
Ms. Catherine Moukheibir
Independent Director
Independent Director
--
--
Dr. Ramnik Xavier
Dr. Ramnik Xavier
Independent Director
Independent Director
--
--
Mr. Spike N. Loy, J.D.
Mr. Spike N. Loy, J.D.
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Kristian Reich
Dr. Kristian Reich
Chief Scientific Officer
Chief Scientific Officer
3.08M
--
Dr. Jorge Santos Da Silva
Dr. Jorge Santos Da Silva
Chief Executive Officer, Director
Chief Executive Officer, Director
3.08M
--
Mr. Matthias Bodenstedt
Mr. Matthias Bodenstedt
Chief Financial Officer
Chief Financial Officer
616.67K
--
Mr. Simon Sturge
Mr. Simon Sturge
Independent Chairman of the Board
Independent Chairman of the Board
171.98K
--
Dr. Andrew J. Phillips
Dr. Andrew J. Phillips
Independent Director
Independent Director
--
--
Dr. Atif Khan
Dr. Atif Khan
Director - Strategic Planning and Projects
Director - Strategic Planning and Projects
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 7月28日 週一
更新時間: 7月28日 週一
持股股東
股東類型
持股股東
持股股東
佔比
BVF Partners L.P.
31.12%
Cormorant Asset Management, LP
13.38%
Fidelity Management & Research Company LLC
8.55%
Reich (Kristian)
4.85%
Santos da Silva (Jorge)
4.85%
Other
37.25%
持股股東
持股股東
佔比
BVF Partners L.P.
31.12%
Cormorant Asset Management, LP
13.38%
Fidelity Management & Research Company LLC
8.55%
Reich (Kristian)
4.85%
Santos da Silva (Jorge)
4.85%
Other
37.25%
股東類型
持股股東
佔比
Hedge Fund
52.91%
Investment Advisor
20.80%
Investment Advisor/Hedge Fund
18.92%
Individual Investor
10.94%
Corporation
4.39%
Research Firm
2.38%
Venture Capital
1.46%
Pension Fund
0.08%
Bank and Trust
0.07%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
325
71.13M
112.06%
-8.47M
2025Q1
329
71.47M
112.59%
-8.98M
2024Q4
308
74.57M
117.86%
+1.09M
2024Q3
292
73.42M
116.42%
+551.38K
2024Q2
282
72.21M
114.78%
+1.82M
2024Q1
274
70.82M
112.58%
-306.27K
2023Q4
260
64.82M
107.09%
-2.17M
2023Q3
219
60.33M
114.64%
-5.55M
2023Q2
175
60.28M
100.54%
+9.44M
2023Q1
123
42.29M
108.00%
-6.15M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
BVF Partners L.P.
19.75M
31.12%
--
--
Mar 31, 2025
Cormorant Asset Management, LP
8.49M
13.38%
--
--
Mar 31, 2025
Fidelity Management & Research Company LLC
5.43M
8.55%
-59.34K
-1.08%
Mar 31, 2025
Reich (Kristian)
3.08M
4.85%
--
--
Mar 15, 2025
Santos da Silva (Jorge)
3.08M
4.85%
--
--
Mar 15, 2025
T. Rowe Price Associates, Inc.
2.97M
4.69%
-369.81K
-11.06%
Mar 31, 2025
MoonLake Immunotherapeutics AG
2.79M
4.39%
+2.69M
+2715.67%
Dec 31, 2023
Avoro Capital Advisors LLC
2.77M
4.36%
--
--
Mar 31, 2025
Citadel Advisors LLC
1.48M
2.33%
-708.23K
-32.39%
Mar 31, 2025
Westfield Capital Management Company, L.P.
1.43M
2.26%
+123.15K
+9.39%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
ALPS Medical Breakthroughs ETF
2.03%
Global X Guru Index ETF
1.53%
Harbor Health Care ETF
1.36%
Virtus LifeSci Biotech Clinical Trials ETF
0.97%
Goldman Sachs Future Health Care Equity ETF
0.63%
iShares Health Innovation Active ETF
0.13%
Nuveen ESG Small-Cap ETF
0.1%
T Rowe Price Small-Mid Cap ETF
0.1%
JPMorgan BetaBuilders US Small Cap Equity ETF
0.09%
Strive Small-Cap ETF
0.07%
查看更多
ALPS Medical Breakthroughs ETF
佔比2.03%
Global X Guru Index ETF
佔比1.53%
Harbor Health Care ETF
佔比1.36%
Virtus LifeSci Biotech Clinical Trials ETF
佔比0.97%
Goldman Sachs Future Health Care Equity ETF
佔比0.63%
iShares Health Innovation Active ETF
佔比0.13%
Nuveen ESG Small-Cap ETF
佔比0.1%
T Rowe Price Small-Mid Cap ETF
佔比0.1%
JPMorgan BetaBuilders US Small Cap Equity ETF
佔比0.09%
Strive Small-Cap ETF
佔比0.07%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
